Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
BMC Cardiovascular Disorders|December 13, 2003
Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjectsEnzo Emanuele, Emmanouil Peros, Piercarlo Minoretti, et al.International Journal of Molecular Medicine|January 14, 2004
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart diseaseEmmanouil Peros, Diego Geroldi, Angela D'Angelo, et al.International Journal of Molecular Medicine|September 10, 2003
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotionEnzo Emanuele, Colomba Falcone, Maria Carabela, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|November 9, 2004
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentationEnzo Emanuele, Emmanouil Peros, Piercarlo Minoretti, et al.American Journal of Nephrology|March 16, 2004
Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patientsEnzo Emanuele, Luigi Segagni Lusignani, Emmanouil Peros, et al.International Journal of Molecular Medicine|May 13, 2004
Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's diseaseEnzo Emanuele, Emmanouil Peros, Giuseppe A Scioli, et al.Minerva Pediatrica|July 21, 2020
An update on biological therapies for pediatric allergic diseasesRiccardo Castagnoli, Maria De Filippo, Martina Votto, et al.Diagnostics (Basel, Switzerland)|September 9, 2023
Selective IgM Deficiency: Evidence, Controversies, and GapsIvan Taietti, Martina Votto, Maria De Filippo, et al.Immunology Letters|May 2, 2015
Impact of passive smoke and/or atopy on adenoid immunoglobulin production in childrenSara Carlotta Tagliacarne, Chiara Valsecchi, Anna Maria Castellazzi, et al.Neuroscience Letters|March 24, 2004
Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's diseaseEnzo Emanuele, Emmanouil Peros, Carmine Tomaino, et al.Pageof 2